Highland Capital Management (Texas)’s Clovis Oncology, Inc. CLVS Stock Holding History

Highland Capital Management (Texas)’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-19,400	Closed	-$570K	–	346
2018 Q3	$570K	Sell	19,400 -5,000	-20%	-$194K	0.03%	206
2018 Q2	$1.11M	Buy	24,400 +6,900	+39%	+$336K	0.06%	160
2018 Q1	$924K	Buy	+17,500	New	+$1.02M	0.05%	188
2016 Q4	–	Sell	-100,000	Closed	-$3.6M	–	350
2016 Q3	$3.6M	Buy	+100,000	New	+$2.15M	0.11%	146
2014 Q4	–	Sell	-265,000	Closed	-$12M	–	263
2014 Q3	$12M	Buy	+265,000	New	+$11.1M	0.45%	64

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Highland Capital Management (Texas)'s CLVS Position: Q4 2018 in Review

Highland Capital Management (Texas) sold out of Clovis Oncology, Inc. (CLVS) in Q4 2018, closing a stake of 19,400 shares — an estimated $570K sold.

Highland Capital Management (Texas) first reported a position in CLVS in Q3 2014 and held it in 5 quarters. The position peaked at $12M in Q3 2014. 165 funds tracked by Wall St. Rank hold CLVS as of Q4 2018.

Highland Capital Management (Texas) reported no remaining Clovis Oncology, Inc. position as of Q4 2018 after selling out during the quarter.
Highland Capital Management (Texas) sold 19,400 Clovis Oncology, Inc. shares in Q4 2018, an estimated $570K.
Highland Capital Management (Texas) first reported a position in Clovis Oncology, Inc. in Q3 2014 and held it in 5 quarters.
Highland Capital Management (Texas)'s Clovis Oncology, Inc. position peaked at $12M in Q3 2014.
165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2018, filed 13 Feb 2019.